| Aortic stenosis in the elderly: difficulties for the clinician | Bernard Iung (Paris, France) | 31 Aug 2011 |
| Is there a need to tailor antiplatelet therapy in diabetes? | Steen Dalby Kristensen (Aarhus N, Denmark) | 31 Aug 2011 |
| Controversial issues in advanced cardiac disease | Mariell Jessup (Philadelphia, United States of America) | 31 Aug 2011 |
| The right ventricle in pulmonary hypertension | Adam Torbicki (Warsaw, Poland) | 31 Aug 2011 |
| Preventing sudden death | Hein Jj Wellens (Maastricht, Netherlands) | 30 Aug 2011 |
| Management of syncope patients. Still a challenge | Emmanuel Simantirakis (Heraklion, Greece) | 30 Aug 2011 |
| Improving care for patients with channelopathies: what's new? | Sylvia G Priori (Pavia, Italy) | 30 Aug 2011 |
| Advances in arrhythmogenic right ventricular cardiomyopathy | Philippe Charron (Paris, France) | 30 Aug 2011 |
| Antiplatelet therapy: how, why, when | Carlo Patrono and Robert F. Storey | 30 Aug 2011 |
| New therapies for mitral regurgitation | Franz Weidinger (Vienna, Austria) | 30 Aug 2011 |
| The great debate - Left main in 2011: CABG or PCI? | Gerhard Wimmer-Greinecker (Bad Bevensen, Germany) | 30 Aug 2011 |
| ESC Guidelines for the management of cardiovascular diseases during pregnancy | Christa Gohlke-Baerwolf (Ballrechten-Dottingen, Germany) | 30 Aug 2011 |
| Imaging in percutaneous valve therapy | Jeroen Bax (Leiden, Netherlands) | 30 Aug 2011 |
| Controversial issues: does imaging improve outcome? | Michael Johannes Zellweger (Basel, Switzerland) | 30 Aug 2011 |
| Neurocardiac imaging: at the heart of electrical disturbances | Nico Bruining (Rotterdam, Netherlands) | 30 Aug 2011 |
| Remote monitoring of cardiac rhythm devices: present and future | Bulent Gorenek (Eskisehir, Turkey) | 30 Aug 2011 |
| The non-responders in cardiac resynchronisation therapy: do we have solutions? | Frank A Flachskampf (Uppsala, Sweden) | 29 Aug 2011 |
| Cardiac pacing. A look to the future | Michael Glikson (Ramat Gan, Israel) | 29 Aug 2011 |
| New evidence beyond guidelines in atrial fibrillation | Jean-Yves Le Heuzey (Paris, France) | 29 Aug 2011 |
| Controversial issues in atrial fibrillation management | Philippe Mabo (Rennes, France) | 29 Aug 2011 |
| Infective endocarditis: an ever changing disease | Roger Hall (Norwich, United Kingdom) | 29 Aug 2011 |
| Controversies in asymptomatic valvular diseases | Ottavio Alfieri (Brescia, Italy) | 29 Aug 2011 |
| Clinical problems in hypertrophic cardiomyopathy | Lorenzo Monserrat (Oleiros, Spain) | 29 Aug 2011 |
| Controversies in myocarditis | Sabine Pankuweit (Marburg, Germany) | 29 Aug 2011 |
| Guidance of antiplatelet treatment | Marco Tubaro (Rome, Italy) | 29 Aug 2011 |
| The challenge of refractory angina | Gaetano A Lanza (Rome, Italy) | 29 Aug 2011 |
| Management of acute coronary syndromes in high-risk patients | Yonathan Hasin (Tiberias, Israel) | 29 Aug 2011 |
| Challenges of in-stent restenosis | Volker Schaechinger (Fulda, Germany) | 29 Aug 2011 |
| Pregnancy and heart disease | Jolien W Roos-Hesselink (Rotterdam, Netherlands) | 29 Aug 2011 |
| State of the Art - Antiplatelet therapy: clinical, genetic and platelet determinants of risk | Jean-Philippe Collet (Paris, France) | 29 Aug 2011 |
| State of the Art - Leucocytes and macrophages in Atherosclerosis: fuel for the fire | Johannes Waltenberger (Muenster, Germany) | 29 Aug 2011 |
| Drug-eluting stent thrombosis in 2011: still an issue? | Larry Dean (Seattle, United States of America) | 29 Aug 2011 |
| How to prevent sudden coronary death in the young | Christina Basso (Padova, Italy) | 29 Aug 2011 |
| Does the presence of chronic kidney disease modify the advice of guidelines? | Keld Per Kjeldsen (Copenhagen, Denmark) | 29 Aug 2011 |
| 2011 Guidelines overview | Jeroen Bax (Leiden, Netherlands) | 29 Aug 2011 |
| Hot topics in echocardiography: the position of the European Association of Echocardiography | Luigi P Badano (Padua, Italy) | 29 Aug 2011 |
| Anti-thrombotic therapy in atrial fibrillation - difficult management scenarios | Gregory Yh Lip (Birmingham, United Kingdom) | 29 Aug 2011 |
| Fractional flow reserve is mandatory for the treatment of multivessel disease | Ganesh Manoharan (Belfast, United Kingdom) | 29 Aug 2011 |
| Controversies in primary percutaneous coronary intervention | Marko Noc (Ljubljana, Slovenia) | 29 Aug 2011 |
| Exercise testing beyond the ST segment | Josef Niebauer (Salzburg, Austria) | 29 Aug 2011 |
| How to advise patients about resuming sports activity | Simon Gibbs (London, United Kingdom) | 29 Aug 2011 |
| Which athlete can re-enter his active sports career? | Antonio Pelliccia (Rome, Italy) | 29 Aug 2011 |
| Strategies for smoking cessation: policy and practice | Joep Perk (Kalmar, Sweden) | 29 Aug 2011 |
| Controversies in hypertension | Per Anton Sirnes (Moss, Norway) | 29 Aug 2011 |
| Controversies in acute coronary syndrome | Dan Atar (Oslo, Norway),
Dr. Thomas von Lueder (Melbourne, AU) | 29 Aug 2011 |
| Developmental signals and adult heart regeneration | Diego Franco (Jaen, Spain) | 29 Aug 2011 |
| Assessing function by echocardiography in valvular heart disease | Jaroslaw Kasprzak (Lodz, Poland) | 29 Aug 2011 |
| Myocardial oedema - a new diagnostic target? | Hakan Arheden (Lund, Sweden)
Matthias G Friedrich (Montreal, CA) | 29 Aug 2011 |
| Interventional cardiovascular magnetic resonance in atrial fibrillation patients - are we on the right path? | Nassir Marrouche (Salt Lake City, United States of America) | 29 Aug 2011 |
| The challenge of arrhythmias in athletes | Hein Heidbuchel (Leuven, Belgium) | 28 Aug 2011 |
| Antithrombotic policies in atrial fibrillation patients | Pekka Raatikainen (Tampere, Finland) | 28 Aug 2011 |
| Cardiac arrhythmias: from gene to bedside | Christian Wolpert (Ludwigsburg, Germany) | 28 Aug 2011 |
| Novel devices for heart failure | William Abraham (Columbus, United States of America) | 28 Aug 2011 |
| Pathophysiology of heart failure with preserved ejection fraction | Lars Siegfried Maier (Gottingen, Germany) | 28 Aug 2011 |
| Pre-and postpartum heart failure | Karen Sliwa-Hahnle (Cape Town, South Africa) | 28 Aug 2011 |
| Treatment targets in acute heart failure | Theresa McDonagh (London, United Kingdom) | 28 Aug 2011 |
| New non-pharmacological approaches to heart failure | Georg Ertl (Wuerzburg, Germany) | 28 Aug 2011 |
| Controversies in low-flow low-gradient aortic stenosis | Raphael Rosenhek (Vienna, Austria) | 28 Aug 2011 |
| Is it time for home treatment of pulmonary embolism? | Menno Huisman (Leiden, Netherlands) | 28 Aug 2011 |
| New approaches to the treatment of pulmonary hypertension | Simon Gibbs (London, United Kingdom) | 28 Aug 2011 |
| Myocardial revascularisation for chronic total coronary oclusion | Tom Mabin (Somerset West, South Africa) | 28 Aug 2011 |
| Controversial issues in diabetes management | Jaakko Tuomilehto (Helsinki, Finland) | 28 Aug 2011 |
| Sudden death and surroundings | Leo L Bossaert (Boechout, Belgium) | 28 Aug 2011 |
| Controversies on new lipid targets | Jane Armitage (Oxford, United Kingdom) | 28 Aug 2011 |
| Obstructive sleep apnea, hypertension and cardiovascular risk | Athanasios John Manolis (Athens, Greece) | 28 Aug 2011 |
| Controversial issues in transcatheter aortic valve implantation | Jean Fajadet (Toulouse, France) | 28 Aug 2011 |
| Emerging concepts on heart rate | Felipe Martinez (Cordoba, Argentina) | 28 Aug 2011 |
| Hypertension and diabetes - deadly challenge | Guido Grassi (Monza, Italy) | 28 Aug 2011 |
| Treating hypertension in difficult settings | Alejandro De La Sierra (Terrassa, Spain) | 28 Aug 2011 |
| Decision making in patients with multivalvular disease | Raphael Rosenhek (Vienna, Austria) | 28 Aug 2011 |
| Managing difficult pulmonary embolism | Simon Gibbs (London, United Kingdom) | 28 Aug 2011 |
| Cardiac resynchronisation therapy: optimising selection and success | Ole A Breithardt (Erlangen, Germany) | 28 Aug 2011 |
| Multimodality imaging heart failure | Jeroen Bax (Leiden, Netherlands) | 28 Aug 2011 |
| Imaging of the right ventricle | Udo Sechtem (Stuttgart, Germany) | 28 Aug 2011 |
| Unprotected left main disease in 2011 | Eric Eeckhout (Lausanne, Switzerland) | 28 Aug 2011 |
| Repeat revascularisation after bypass surgery: a real challenge | Javier Escaned (Madrid, Spain) | 28 Aug 2011 |
| Controversial issues in cardiovascular prevention - where does high-density lipoprotein stand? | Julian Halcox (Cardiff, United Kingdom) | 28 Aug 2011 |
| MicroRNAs - a novel target in cardiovascular prevention | Manuel Mayr (London, United Kingdom) | 28 Aug 2011 |
| Controversial issue: are women different? | Grethe S Tell (Bergen, Norway) | 28 Aug 2011 |
| Imaging in preventive cardiology: indication and cost effectiveness | Eike Nagel (London, United Kingdom) | 28 Aug 2011 |
| Hot topics in hypertension | Renata Cifkova (Prague, Czech Republic) | 28 Aug 2011 |
| Genetic determinants of cardiovascular disease: are genome-wide association studies the whole answer? | Stefan Kääb (Munich, Germany) | 28 Aug 2011 |
| Inflammation as a modulator of cardiac remodelling | Lars Gullestad (Oslo, Norway) | 28 Aug 2011 |
| Echocardiography in infective endocarditis | Manuel J Antunes (Coimbra, Portugal) | 28 Aug 2011 |
| Benefits of three-dimensional echocardiography in daily clinical practice | Mark J Monaghan (London, United Kingdom) | 28 Aug 2011 |